BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31714880)

  • 1. Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients.
    Florin L; Rubben K; Vanhaecke A; Devreese K; De Keyser F; Smith V; Bonroy C
    Clin Chem Lab Med; 2020 Feb; 58(3):416-423. PubMed ID: 31714880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
    Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
    J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.
    Assassi S; Fritzler MJ; Arnett FC; Norman GL; Shah KR; Gourh P; Manek N; Perry M; Ganesh D; Rahbar MH; Mayes MD
    J Rheumatol; 2009 Oct; 36(10):2250-6. PubMed ID: 19723904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
    Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies.
    Öztürk Ö; Dos Santos Duarte SD; Balaban HY; Şimşek H; Şener B
    Turk J Med Sci; 2022 Apr; 52(5):1697-1703. PubMed ID: 36422475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis.
    Imura-Kumada S; Hasegawa M; Matsushita T; Hamaguchi Y; Encabo S; Shums Z; Norman GL; Takehara K; Fujimoto M
    Mod Rheumatol; 2012 Nov; 22(6):892-8. PubMed ID: 22327744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis.
    Villalta D; Seaman A; Tiongson M; Warren C; Bentow C; Bizzaro N; Alessio MG; Porcelli B; Norman GL; Mahler M
    Clin Chem Lab Med; 2020 Aug; 58(9):1499-1507. PubMed ID: 32286240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.
    Zhu YJ; Li J; Liu YG; Jiang Y; Cheng XJ; Han X; Wang CY; Li J
    World J Gastroenterol; 2023 Sep; 29(34):5075-5081. PubMed ID: 37753365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis.
    Liberal R; Grant CR; Sakkas L; Bizzaro N; Bogdanos DP
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):572-85. PubMed ID: 23876351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.
    Terziroli Beretta-Piccoli B; Stirnimann G; Mertens J; Semela D; Zen Y; Mazzucchelli L; Voreck A; Kolbus N; Merlo E; Di Bartolomeo C; Messina P; Cerny A; Costantini S; Vergani D; Mieli-Vergani G;
    J Autoimmun; 2021 Jan; 116():102578. PubMed ID: 33229138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities.
    Parveen S; Morshed SA; Nishioka M
    J Gastroenterol Hepatol; 1995; 10(4):438-45. PubMed ID: 8527711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
    Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
    J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay.
    Villalta D; Sorrentino MC; Girolami E; Tampoia M; Alessio MG; Brusca I; Daves M; Porcelli B; Barberio G; Bizzaro N;
    Clin Chim Acta; 2015 Jan; 438():135-8. PubMed ID: 25172039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature.
    de Liso F; Matinato C; Ronchi M; Maiavacca R
    Clin Chem Lab Med; 2017 Nov; 56(1):25-31. PubMed ID: 28731850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China.
    Liu H; Liu Y; Wang L; Xu D; Lin B; Zhong R; Gong S; Podda M; Invernizzi P
    BMC Gastroenterol; 2010 Sep; 10():100. PubMed ID: 20815889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-mitochondrial antibodies detection assays for diagnosis of primary biliary cholangitis in southern Tunisia population.
    Mejdoub S; Hamza Z; Hachicha H; Chtourou L; Marrzouk S; Feki S; Jerbi A; Boukthir S; Bahloul Z; Tahri N; Masmoudi H
    Ann Biol Clin (Paris); 2022 Sep; 80(5):423-429. PubMed ID: 36453746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
    Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
    Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
    Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
    Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?
    Sun C; Xiao X; Yan L; Sheng L; Wang Q; Jiang P; Lian M; Li Y; Wei Y; Zhang J; Chen Y; Li B; Li Y; Huang B; Li Y; Peng Y; Chen X; Fang J; Qiu D; Hua J; Tang R; Leung P; Gershwin ME; Miao Q; Ma X
    J Autoimmun; 2019 May; 99():33-38. PubMed ID: 30709684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
    Zhao DT; Liu YM; Han Y; Zhang HP; Zhao Y; Yan HP
    Medicine (Baltimore); 2020 Jan; 99(3):e18856. PubMed ID: 32011506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.